The hyperphosphorylated p-MAPK3/1 (ERK1/2) in DCM could indicate the degree of activation that may influence the effects of this pathway [72] and determine whether progression towards DCM or HCM occurs. Here, MAPK3 is linked to familial dilated cardiomyopathy.